SEC 13F Intelligence

Swiss National Bank / PFE

Swiss National Bank’s Pfizer Inc Position

Does Swiss National Bank own Pfizer Inc (PFE)? Yes — 16.69M shares worth $469M (+0.27% of its 13F portfolio) as of Q1 2026, up from 15.58M shares the prior filed quarter.

Position Value
$469M
Q1 2026
Shares
16.69M
% of Portfolio
+0.27%
Quarters Held
30
currently held

Position History PFE

Reported value by quarter
Q4 ’18: $912MQ4 ’18Q1 ’19: $900MQ2 ’19: $864MQ3 ’19: $722MQ4 ’19: $747MQ4 ’19Q1 ’20: $752MQ2 ’20: $764MQ3 ’20: $848MQ4 ’20: $828MQ4 ’20Q1 ’21: $830MQ2 ’21: $891MQ3 ’21: $952MQ4 ’21: $1.3BQ4 ’21Q1 ’22: $1.3BQ2 ’22: $1.3BQ3 ’22: $1.1BQ4 ’22: $1.2BQ4 ’22Q1 ’23: $909MQ2 ’23: $748MQ3 ’23: $602MQ4 ’23: $508MQ4 ’23Q1 ’24: $469MQ2 ’24: $468MQ3 ’24: $487MQ4 ’24: $425MQ4 ’24Q1 ’25: $405MQ2 ’25: $416MQ3 ’25: $418MQ4 ’25: $388MQ4 ’25Q1 ’26: $469Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202616.69M$469M+0.27%
Q4 202515.58M$388M+0.23%
Q3 202516.39M$418M+0.24%
Q2 202517.17M$416M+0.25%
Q1 202515.98M$405M+0.29%
Q4 202416.01M$425M+0.28%
Q3 202416.82M$487M+0.32%
Q2 202416.72M$468M+0.32%
Q1 202416.91M$469M+0.33%
Q4 202317.65M$508M+0.37%
Q3 202318.16M$602M+0.47%
Q2 202320.39M$748M+0.51%
Q1 202322.28M$909M+0.62%
Q4 202222.81M$1.2B+0.84%
Q3 202224.32M$1.1B+0.76%
Q2 202224.39M$1.3B+0.87%
Q1 202224.31M$1.3B+0.71%
Q4 202121.31M$1.3B+0.76%
Q3 202122.13M$952M+0.61%
Q2 202122.74M$891M+0.55%
Q1 202122.90M$830M+0.55%
Q4 202022.50M$828M+0.59%
Q3 202023.10M$848M+0.66%
Q2 202023.37M$764M+0.65%
Q1 202023.04M$752M+0.80%
Q4 201919.05M$747M+0.77%
Q3 201920.09M$722M+0.77%
Q2 201919.95M$864M+0.93%
Q1 201921.19M$900M+0.99%
Q4 201820.90M$912M+1.17%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Swiss National Bank’s full portfolio or all institutional holders of PFE.